Advertisement

Does AMP-activated Protein Kinase Couple Inhibition of Mitochondrial Oxidative Phosphorylation by Hypoxia to Pulmonary Artery Constriction?

  • A.M. EVANS
  • KIRSTEEN J.W. MUSTARD
  • CHRISTOPHER N. WYATT
  • MICHELLE DIPP
  • NICHOLAS P. KINNEAR
  • D. GRAHAME HARDIE
Part of the ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY book series (AEMB, volume 580)

Abstract

Pulmonary arteries constricts in response to hypoxia and thereby aid ventilation-perfusion matching in the lung. Although O2-sensitive mechanisms independent of mitochondria may also play a role, it is generally accepted that relatively mild hypoxia inhibits mitochondrial oxidative phosphorylation and that this underpins, at least in part, cell activation2-6. Despite this consensus, the mechanism by which inhibition of mitochondrial oxidative phosphorylation couples to Ca2+-dependent vasoconstriction has remained elusive. To date, the field has focussed on the role of the cellular energy status (ATP), reduced redox couples and reactive oxygen species4,5 respectively, but investigation of these hypotheses has delivered conflicting data and failed to unite the field8.

Keywords

Pulmonary Artery AMPK Activation Hypoxic Pulmonary Vasoconstriction Mitochondrial Oxidative Phosphorylation Pulmonary Arterial Smooth Muscle Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    von Euler US, Liljestrand G. Observations on the pulmonary arterial blood pressure in the cat. Acta Physiol. Scand. 1946;12, 301–320.CrossRefGoogle Scholar
  2. 2.
    Rounds S, McMurtry IF. Inhibitors of oxidative ATP production cause transient vasoconstriction and block subsequent pressor responses in rat lungs. Circ. Res. 1981;48: 393–400.PubMedGoogle Scholar
  3. 3.
    Archer SL, Will JA, Weir EK. Redox status in the control of pulmonary vascular tone. Herz 1986;11: 127–141.PubMedGoogle Scholar
  4. 4.
    Killilea DW, Hester R, Balczon R, Babal P, Gillespie MN. Free radical production in hypoxic pulmonary artery smooth muscle cells. Am. J. Physiol. 2000;279: L408–L412.Google Scholar
  5. 5.
    Waypa GB, Chandel NS, Schumacker PT. Model for hypoxic pulmonary vasoconstriction involving mitochondrial oxygen sensing. Circ. Res. 2001; 88: 1259–1266.PubMedGoogle Scholar
  6. 6.
    Leach RM, Hill HS, Snetkov VA, Robertson TP, Ward JPT. Divergent roles of glycolysis and the mitochondrial electron transport chain in hypoxic pulmonary vasoconstriction of the rat. Identity of the hypoxic sensor. J. Physiol. 2001;536: 211–224.PubMedCrossRefGoogle Scholar
  7. 7.
    Buescher PC, Pearse DB, Pillai RP, Litt MC, Mitchell MC, Sylvester JT. Energy state and vasomotor tone in hypoxic pig lungs. J. Appl. Physiol. 1991;70: 1874–1881.PubMedCrossRefGoogle Scholar
  8. 8.
    Gonzalez C, Sanz-Alfayate G, Agapito T, Gomez-Nino A, Rocher A, Obeso A. Significance of ROS in oxygen sensing in cell systems with sensitivity to physiological hypoxia. Respiratory Physiol. Neurobiol. 2002;132: 17–41.CrossRefGoogle Scholar
  9. 9.
    Hardie DG, Scott JW, Pan DA, Hudson ER. Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett. 2003;546: 113–120.PubMedCrossRefGoogle Scholar
  10. 10.
    Hardie DG. The AMP-activated protein kinase pathway – new players upstream and downstream. J. Cell Sci. 2004; 117: 5479–5487.PubMedCrossRefGoogle Scholar
  11. 11.
    Hardie DG, Hawley SA. AMP-activated protein kinase: the energy charge hypothesis revisited. BioEssays 2001;23: 1112–1119.PubMedCrossRefGoogle Scholar
  12. 12.
    Hawley SA, Selbert MA, Goldstein EG. 5′-AMP activates the AMP-activated protein kinase cascade, and Ca2+/calmodulin activates the calmodulin-dependent protein kinase I cascade, via three independent mechanisms. J. Biol. Chem. 1995;270: 27186–27191.PubMedCrossRefGoogle Scholar
  13. 13.
    Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, Makela TP, Alessi DR, Hardie DG. Complexes between the LKB1 tumor suppressor, STRAD□/□ and MO25□/□ are upstream kinases in the AMP-activated protein kinase cascade. J. Biol. 2003;2: 28.PubMedCrossRefGoogle Scholar
  14. 14.
    Shaw RJ, Bardeesy N, Manning BD, Lopez L, Kosmatka M, DePinho RA, Cantley LC. The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell 2004;6: 91–99.PubMedCrossRefGoogle Scholar
  15. 15.
    Woods A, Johnstone SR, Dickerson K, Leiper FC, Fryer LG, Neumann D, Schlattner U, Wallimann T, Carlson M, Carling D. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr. Biol. 2003;13: 2004–2008.PubMedCrossRefGoogle Scholar
  16. 16.
    Evans AM 2004 Hypoxia cell metabolism and cADPR accumulation. In: Yuan X-J (ed) Hypoxic pulmonary vasoconstriction: cellular and molecular mechanisms. Kluwer Academic Publications, p 313–338.Google Scholar
  17. 17.
    Dipp M, Nye PCG, Evans AM. Hypoxic release of calcium from the sarcoplasmic reticulum of pulmonary artery smooth muscle. Am. J. Physiol. 2001;281: L318–L325.Google Scholar
  18. 18.
    Durante PE, Mustard KJ, Park SH, Winder WW, Hardie DG. Effects of endurance training on activity and expression of AMP-activated protein kinase isoforms in rat muscles. Am. J. Physiol. 2002;283: E 178–86.Google Scholar
  19. 19.
    Cheung PC, Salt IP, Davies SP, Hardie DG, Carling D. Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding. Biochem. J. 2000;346, 659–669.PubMedCrossRefGoogle Scholar
  20. 20.
    Schrauwen P, Hardie DG, Roorda B, Clapham JC, Abuin A, Thomason-Hughes M, Green K, Frederik PM, Hesselink MK. Improved glucose homeostasis in mice overexpressing human UCP3: arole for AMP-kinase? Int J Obes Relat Metab Disord. 2004;28: 824–828.PubMedCrossRefGoogle Scholar
  21. 21.
    Wilson HL, Dipp M, Thomas JM, Lad C, Galione A, Evans AM. ADP-ribosyl cyclase and cyclic ADP-ribose hydrolase act as a redox sensor: A primary role for cyclic ADP-ribose in hypoxic pulmonary vasoconstriction. J. Biol. Chem. 2001;276: 11180–11188.PubMedCrossRefGoogle Scholar
  22. 22.
    Dipp M, Evans AM. cADPR is the primary trigger for hypoxic pulmonary vasoconstriction in the rat lung in-situ. Circ. Res. 2001;89: 77–83.PubMedGoogle Scholar
  23. 23.
    Corton JM, Gillespie JG, Hawley SA, Hardie DG. 5-Aminoimidazole-4-carboxamide ribonucleoside: a specific method for activating AMP-activated protein kinase in intact cells? Eur. J. Biochem. 1995;229: 558–565.PubMedCrossRefGoogle Scholar
  24. 24.
    Lee HC, Walseth TF, Bratt GT, Hayes RN Clapper DL. Structural determination of a cyclic metabolite of NAD with intracellular calcium-mobilizing activity. J. Biol. Chem. 1989;264: 1608–1615.PubMedGoogle Scholar
  25. 25.
    Galione A, Lee HC, Busa WB. Ca2+-induced Ca2+ release in sea urchin egg homogenates: modulation by cyclic ADP-ribose. Science 1991;253: 1143–1146.PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2006

Authors and Affiliations

  • A.M. EVANS
    • 1
  • KIRSTEEN J.W. MUSTARD
    • 2
  • CHRISTOPHER N. WYATT
    • 1
  • MICHELLE DIPP
    • 1
  • NICHOLAS P. KINNEAR
    • 1
  • D. GRAHAME HARDIE
    • 2
  1. 1.Department of Biomedical Sciences, School of Biology, Bute BuildingUniversity of St AndrewsSt. AndrewsUK.
  2. 2.Division of Molecular Physiology, School of Life Sciences, Wellcome Trust BiocentreUniversity of DundeeUK.

Personalised recommendations